Exclusive: Free HPV Vaccine Drive Launched in Visakhapatnam to Combat Cervical Cancer

Visakhapatnam, India – July 19, 2025 – In a meaningful public health initiative, Visakhapatnam South MLA vamsi Krishna Srinivas has championed a proactive approach to preventing cervical cancer, urging parents to prioritize HPV vaccination for their daughters. A crucial free HPV vaccine drive is set to commence in August for girls aged 9 to 14 attending Government Queen Mary’s High School.This vital program, spearheaded by the Lions Club of Vizag Charitable Trust and Chaitanya Sravanthi, is made possible through the generous support of the Visakhapatnam Port Authority (VPA). The drive aims to protect the community’s young women from a perhaps devastating disease.During an awareness camp held at Queen Mary’s High School, Mr. Vamsi Krishna Srinivas emphasized that vaccination stands as the most effective shield against cervical cancer. Chaitanya Sravanthi president Shirin Rahman confirmed the VPA’s sponsorship,outlining the vaccination schedule: the first dose in August,followed by the second in February 2026.

Dr. I. Vani, Superintendent of King George Hospital (KGH), underscored the necessity of vaccinating girls in the designated age bracket.She also highlighted KGH’s commitment to early detection through ongoing Pap smear tests. V. Uma Maheswar Rao,managing trustee of Lions Cancer and General Hospital,added that awareness campaigns are being actively conducted across rural and urban areas,with a particular focus on underserved communities.

Evergreen Insight: Cervical cancer remains a significant global health concern, particularly for women. The Human Papillomavirus (HPV) is the primary cause of this disease. Vaccination against HPV, especially before the onset of sexual activity, is a cornerstone of preventative healthcare. This initiative in Visakhapatnam serves as a powerful model for other regions, demonstrating the impact of community collaboration and public-private partnerships in safeguarding public health. Early detection through regular screenings, such as Pap smears, alongside primary prevention through vaccination, creates a robust defense against cervical cancer, empowering women with better health outcomes.

what are the long-term implications of widespread HPV vaccination on cervical cancer rates?

HPV Vaccination Drive to Protect Girls in August

Understanding the HPV Threat & Why Vaccination Matters

human Papillomavirus (HPV) is a remarkably common viral infection.As highlighted by research, there are over 200 types of HPV, with some posing critically important health risks, notably for women. HPV is primarily transmitted through skin-to-skin contact, most commonly during sexual activity. While many HPV infections clear up on their own, persistent infections can lead to cervical cancer, other cancers (vaginal, vulvar, anal, penile, and oropharyngeal), and genital warts.

The upcoming HPV vaccination drive in August is a crucial step in safeguarding the health of young girls and preventing these potentially devastating outcomes. This initiative focuses on providing accessible and affordable HPV vaccines to eligible individuals.

The August Vaccination Drive: Key Details

This nationwide HPV vaccination campaign is scheduled to launch in August 2025,targeting girls aged 9-14 years. the drive aims to significantly increase HPV immunization rates and reduce the incidence of HPV-related diseases.

Here’s a breakdown of what you need to know:

Target Group: Girls aged 9-14 years are the primary focus. While the vaccine is most effective when administered before the onset of sexual activity, discussions with healthcare providers are encouraged for individuals outside this age range.

Vaccine type: The drive will utilize the latest generation of HPV vaccines, offering protection against a wider range of HPV types, including those responsible for the majority of cervical cancers.

Dosage Schedule: The vaccination schedule typically involves two doses, administered six to twelve months apart. Specific guidelines may vary based on age at the time of the frist dose.

Vaccination Locations: vaccines will be available at designated schools, community health centers, and participating hospitals. A comprehensive list of locations will be published on the Ministry of Health’s website and through local health authorities.

Cost: The government is subsidizing the HPV vaccine cost to ensure affordability and accessibility for all eligible girls.

Reduced Cancer Risk: Significantly lowers the risk of cervical, vaginal, vulvar, anal, and oropharyngeal cancers.

Prevention of Genital Warts: Protects against the HPV types that cause genital warts, a common and frequently enough distressing condition.

Herd Immunity: High vaccination rates contribute to herd immunity, protecting even those who are not vaccinated.

Long-Term Health Security: Investing in HPV prevention today translates to a healthier future for generations to come.

Reduced Healthcare Burden: Lowering the incidence of HPV-related diseases reduces the strain on healthcare systems.

Addressing Common Concerns & Myths about HPV Vaccines

Despite the overwhelming scientific evidence supporting the safety and efficacy of HPV vaccines, several myths and concerns persist. Let’s address some of the most common ones:

Myth: the vaccine causes infertility. Fact: Numerous studies have debunked this claim. HPV vaccines do not affect fertility.

Myth: The vaccine encourages early sexual activity. Fact: There is no evidence to support this. Vaccination is recommended before the onset of sexual activity.

Myth: The vaccine has serious side effects. Fact: Like all vaccines, HPV vaccines can cause mild side effects such as pain or swelling at the injection site, fever, or headache. Serious side effects are extremely rare.

Concern: what if my daughter is already sexually active? Fact: While the vaccine is most effective before sexual activity, it can still provide benefit to those who have already been exposed to HPV. Consult with a healthcare professional for personalized advice.

Real-World Impact: Australia’s Success Story

Australia has been a global leader in HPV vaccination programs. Since implementing a national school-based HPV vaccination program in 2007,the country has witnessed a dramatic reduction in HPV infections and pre-cancerous cervical abnormalities. Studies have shown a significant decline in genital wart diagnoses and a projected considerable decrease in cervical cancer rates in the coming decades. This success story demonstrates the transformative potential of widespread HPV immunization.

Practical Tips